07:00 , May 9, 2016 |  BioCentury  |  Emerging Company Profile

Deliver to the liver

Topas Therapeutics GmbH is turning a shortcoming of nanoparticles - difficulty escaping the liver - into an advantage. The company is targeting a subset of liver cells that are among the most tolerizing in the...
01:24 , Mar 23, 2016 |  BC Extra  |  Financial News

Topas spins out of Evotec, raises series A

Evotec AG (Xetra:EVT) spun out Topas Therapeutics GmbH (Hamburg, Germany), which plans to develop nanoparticle-based therapeutics that will induce antigen-specific immune tolerance in the liver to treat autoimmune and inflammatory diseases. Topas also raised EUR...
07:00 , Apr 3, 2014 |  BC Innovations  |  Strategy

Bridging the German gap

Evotec AG 's purchase of Bionamics GmbH gives it access to a collection of autoimmune assets sourced from German universities. The move is the latest in a series of steps taken by Evotec to build...
07:00 , Mar 31, 2014 |  BC Week In Review  |  Company News

Bionamics GmbH, Evotec deal

Evotec acquired asset management company Bionamics for an undisclosed amount in cash. Bionamics will be eligible for undisclosed milestones. Bionamics focuses on translating academic innovations to assets for the biotech and pharma industry and manages...
07:00 , Jun 24, 2013 |  BC Week In Review  |  Company News

Lophius Biosciences neurology news

Lophius joined the NEU2 consortium with a two-year project to develop the T-Track MS as a blood-based diagnostic test to support the initial diagnosis of multiple sclerosis and enable monitoring of disease progression. The project...